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Inflammation could be involved in some neurodegenerative disorders that accompany signs of inflammation. However, because
sensitivity to inflammation is not equal in all brain structures, a direct relationship is not clear. Our aim was to test whether some
physiological circumstances, such as stress, could enhance susceptibility to inflammation in the prefrontal cortex (PFC), which
shows a relative resistance to inflammation. PFC is important in many brain functions and is a target for some neurodegenerative
diseases. We induced an inflammatory process by a single intracortical injection of 2 g of lipopolysaccharide (LPS), a potent
proinflammogen, in nonstressed and stressed rats. We evaluated the effect of our treatment on inflammatory markers, neuronal
populations, BDNF expression, and behavior of several mitogen-activated protein (MAP) kinases and the transcription factor
cAMP response element-binding protein. Stress strengthens the changes induced by LPS injection: microglial activation and
proliferation with an increase in the levels of the proinflammatory cytokine tumor necrosis factor-; loss of cells such as astroglia,
seen as loss of glial fibrillary acidic protein immunoreactivity, and neurons, studied by neuronal-specific nuclear protein immu-
nohistochemistry and GAD67 and NMDA receptor 1A mRNAs expression by in situ hybridization. A significant increase in the
BDNFmRNA expression andmodifications in the levels of MAP kinase phosphorylation were also found. In addition, we observed
a protective effect from RU486 [mifepristone (11-[p-(dimethylamino)phenyl]-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-
one)], a potent inhibitor of the glucocorticoid receptor activation. All of these data show a synergistic effect between inflammation
and stress, which could explain the relationship described between stress and some neurodegenerative pathologies.
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Introduction
Pathological processes of neurodegeneration such as those ob-
served in Alzheimer’s (AD) and Parkinson’s diseases are accom-
panied by an inflammatory reaction that is believed to contribute
to pathogenesis (Akiyama et al., 2000).We previously studied the
involvement of inflammatory reactions in the degeneration of the
nigrostriatal dopaminergic system (Toma´s-Camardiel et al.,
2004), which is preceded by extensive microglial activation in
substantia nigra (SN), suggesting the possible relationship be-
tween the two processes. However, despite the fact that evidence
for a chronic inflammatory reaction in the brain is particularly
strong in AD (McGeer andMcGeer, 2004), no direct relationship
has been reported between the degenerative processes and in-
flammation in brain structures.
Lipopolysaccharide (LPS) is a potent inductor of inflamma-
tion and produces the activation of microglia and astrocytes
(Lieberman et al., 1989; Benveniste et al., 1990; Chung and Ben-
veniste, 1990) and the induction of diverse cytokines (Lee et al.,
1993; Chao et al., 1995; Jeohn et al., 1998). Injection of LPS in the
prefrontal cortex (PFC) does not have a similar effect as in SN
(Kim et al., 2000). This suggests a lower response to LPS challenge
in PFC than in other structures such as SN. Thus, we sought for
conditions that could enhance the inflammatory response to LPS
injection. Regarding this, some conditions have been suggested as
circumstances to increase the risk of developing AD. Stress is a
condition of human experience and includes not only major life
events but also the hassles of daily life that elevate activities of
physiological systems so as to cause disruption of ongoing ho-
meostasis. It reflects individual experience and genetic back-
ground; therefore, reactions to a stressful incident are highly vari-
able (McEwen, 2000, 2002). Stress is widely acknowledged as a
predisposing and precipitating factor in psychiatric illnesses
(Kendler and Karkowski-Shuman, 1997; Caspi et al., 2003). Re-
peated stress causes changes in the PFC and amygdala (Mazure et
al., 1995; Yokoyama and Sasaki, 1999; Wellman, 2001; Trentani
et al., 2002; Vyas et al., 2002; Gerrits et al., 2003; Radley et al.,
2004). Evidence illustrates atrophy and cell death of stress-
vulnerable neurons in PFC; stress has been recognized as strongly
influencing cognitive and emotional processes subserved by PFC
(Arnsten, 1998).
The aim of the present work was to test whether a chronic
variate stress could enhance the LPS-induced damage in PFC.
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Immunohistochemical and molecular biology techniques were
combined in an effort to elucidate the effects of chronic stress,
intracortical LPS injection, and a combination of both on differ-
ent cell types of the PFC. We found that stress significantly in-
creased the inflammatory damage induced by LPS. Thus, we also
studied the effect produced by RU486 [mifepristone (11-[p-
(dimethylamino)phenyl]-17-hydroxy-17-(1-propynyl)estra-
4,9-dien-3-one)], a potent inhibitor of the glucocorticoid recep-
tor (GR) activation, on the different parameters assayed.
Materials andMethods
Animals and surgery.Male albino Wistar rats (200–300 g) were used for
these studies. The rats were kept at constant room temperature of 22
1°C and relative humidity (60%) with a 12 h light/dark cycle with access
to food andwater ad libitum. Rats were anesthetized with chloral hydrate
(400 mg/kg) and positioned in a stereotaxic apparatus (Kopf Instru-
ments, Tujunga, CA) to conform to the brain atlas of Paxinos and
Watson (1986). Injections into the PFC were made 3.2 mm anterior, 1.3
mm lateral, and 3.5 mm ventral to the bregma.
Experiments were performed in accordance with the Guidelines of the
European Union Council (86/609/EU), following the Spanish regula-
tions (BOE 67/8509-12, 1988) for the use of laboratory animals and
approved by the Scientific Committee of the University of Seville.
Five groups of animals were established according to the different
treatments. (1) The vehicle-injected group received a single dose of 2 l
of Monastral Blue inert tracer (Sigma, St. Louis, MO) (1% in PBS) in the
left PFC. (2) The vehicle/stressed group received a single dose of 2 l of
Monastral Blue inert tracer in the left PFC and was stressed for 9 d. (3)
The LPS-injected group received a single dose of LPS (2 g; from Esche-
richia coli, serotype 026:B6; Sigma) dissolved in 2 l of vehicle in the left
PFC. (4) The LPS/stressed group received a single intracortical injection
of 2 g of LPS and was stressed for 9 d. (5) The LPS/stressed/RU486
group received a single intracortical injection of 2g of LPS, was stressed
for 9 d, and received a daily dose of RU486 (Sigma) (20 mg/kg in saline
20% DMSO) 1 h after the 9 d stress. All animals were killed by decapita-
tion 10 d after surgery. At least five animals were used for each group.
Body weight was measured at the beginning and at the end of the treat-
ment. After killing the animals, the adrenal glandweight was evaluated as
an indirect parameter of hypothalamic–pituitary–adrenal (HPA) axis
activation.
Stress model. Chronic variate stress was adapted from other models of
variate stress (Willner et al., 1987; Konarska et al., 1990; Papp et al., 1991;
Murua and Molina, 1992; Muscat et al., 1992; Gamaro et al., 2003) with
modifications. Animals were divided in stressed and nonstressed groups.
Nonstressed animals were kept undisturbed in their home cages during
the 10 d of treatment. A 9 d variate-stressor paradigm was used for
animals in the stressed groups. Individual stressors and length of time
applied each day are listed in Table 1. The following stressors were used:
(1) 24 h of food deprivation; (2) 24 h of water deprivation; (3) 1–3 h of
restraint, as described below; (4) 1.5–2 h of restraint at 4°C; and (5)
forced swimming during 10 min, as described below. Application of
stress started at a different time everyday to minimize predictability.
Restraint was performed by placing the animal in a 21 6 cmplastic tube
and adjusting it with plaster tape on the outside so that the animal was
unable tomove. Therewas a 6 cmhole at the far end for breathing. Forced
swimming was performed by placing the animal in a glass tank measur-
ing 44 33 30 cm with 22 cm of water depth at 23 2°C.
Immunohistological evaluation: glial fibrillary acidic protein, OX-6, and
neuronal-specific nuclear protein. Rats were perfused through the heart
under deep anesthesia (chloral hydrate) with 150–200ml of 4% parafor-
maldehyde in phosphate buffer, pH 7.4. The brains were removed and
then cryoprotected serially in sucrose in PBS, pH 7.4, first in 10% sucrose
for 24 h and then in 30% sucrose until sunk (2–5 d). Brains were then
frozen in isopentane at15°C, and 25msections were cut on a cryostat
and mounted in gelatin-coated slides. Primary antibodies used were
mouse-derived anti-glial fibrillary acidic protein (GFAP) (1:300; Chemi-
con, Temecula, CA), mouse-derived OX-6 (1:200; Serotec, Oxford, UK)
andmouse-derived anti-neuronal nuclei [neuronal-specific nuclear pro-
tein (NeuN), 1:2000; Chemicon]. Sections were washed and then treated
with 0.3% hydrogen peroxide inmethanol for 30min, washed again, and
incubated in a solution containingTBS and 1%horse serum for 60min in
a humid chamber. Slides were drained and further incubated with the
primary antibody in TBS containing 1% horse serum and 0.25% Triton
X-100 for 24 h. Sections were then incubated for 2 h with biotinylated
horse anti-mouse IgG (1:200; Vector Laboratories, Burlingame, CA),
followed by a second 1 h incubation with ExtrAvidin peroxidase solution
(1:100; Sigma). The antibody was diluted in TBS containing 0.25% Tri-
ton X-100 (TBST), and its addition was preceded by three 10 min rinses
in TBS. The peroxidase was visualized with a standard diaminobenzi-
dine/hydrogen reaction for 5 min.
Histochemistry data analysis: quantification of tissue areas.AnAnalySIS
image software (Soft Imaging System, Mu¨nster, Germany) coupled to a
Polaroid (Bedfordshire,UK)DMCcamera attached to a Leica (Nussloch,
Germany) lightmicroscopewas used for allmeasurements. Areas lacking
GFAP andNeuN immunoreactivity weremeasured. Cells showing OX-6
immunoreactivity were counted using five fields per section and five
sections per animal.
Measurement of dopamine and 3,4-dihydroxyphenylacetic. HPLC with
electrochemical detection was used for the determination of dopamine
(DA) and its metabolite 3,4-dihydroxyphenylacetic (DOPAC). Analyses
were performed as described previously (Herrera et al., 1993). Forty-five
animals were used for these experiments.
Preparation of riboprobes. pBluescript SK plasmids, containing the
cDNA sequence for glutamic acid decarboxylase 67 (GAD67) as a 3.2 kb
EcoRI insert (clones 14 and 18), were kindly provided by Dr. A. Tobin
(University of California, Los Angeles, Los Angeles, CA). The GAD67
cDNAwas isolated from a 1 gt-11 cDNA librarymade frompoly(A) RNA
from adult rat brain (Erlander et al., 1991). To prepare the GAD67 anti-
sense transcript, clone 14 was digested with SalI and used as a template
with the T3 RNA polymerase. To prepare the GAD67 sense transcript,
clone 18 was digested with SalI and used as a template with the T3 RNA
polymerase.
pBluescript SK plasmids, containing the cDNA sequence for NMDA
receptor 1A (NMDAR1A) were kindly provided by Dr. S. Heinemann
(Salk Institute, San Diego, CA). To prepare the NMDAR1A antisense
riboprobe, plasmid pBluescript SK was linearized with EcoRI and used as
a template with the T7 RNA polymerase. NMDAR1A sense riboprobe
was generated after XholI digestion by using the T3 RNA polymerase.
BDNF-specific riboprobes were transcribed from a 460 bp template of
rat BDNF codon subcloned into a PGEM-4Z vector (Promega,Madison,
WI) kindly provided byGenentech (South San Francisco, CA). Sense and
antisense transcripts were generated using SP6 and T7 polymerases, re-
spectively (Research Biochemicals, Natick, MA) fromHindIII and EcoRI
fragments of the vector.
Sense and antisense riboprobes used for in situ hybridization were
transcribed in the presence of [ 35S]UTP (1300 Ci/mmol; Amersham
Biosciences, Little Chalfont, UK).
Isotopic in situ hybridization histochemistry. In situ hybridization on
brain frozen sections was performed following a modification of a pro-
cedure described in detail previously (Pasinetti et al., 1989). Thaw-
mounted 12 m sections were postfixed for 30 min in 4% paraformal-
dehyde, followed by three 10 min washes in PBS, pH 7.4. Sections were
treated for 1 min in 0.1 M triethanolamine, followed by 10 min in acetic
Table 1. Schedule of stressing agents used during the chronic stress treatment
Day of treatment Agent used Duration
1 Forced swimming 10 min
2 Restraint 3 h
3 Water deprivation 24 h
4 Restrain at 4°C 1.5 h
5 Restraint 3 h
6 Food deprivation 24 h
7 Water deprivation 24 h
8 Restrain at 4°C 2 h
9 Food deprivation 24 h
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anhydride/0.1 M triethanolamine to decrease nonspecific binding. After a
1 min wash in 2 SSC, sections were dehydrated in a series of increasing
concentrations of ethanol and then air dried. The sections were hybrid-
ized for 3 h at 50°C with the [ 35S] cRNA, rinsed in 4 SSC/20 mM DTT,
and then 4 SSC alone. Sections were subjected to 30 min of RNase
digestion at 37°C (20g/ml RNase A in 0.5 MNaCl, 0.01 M Tris-HCl, and
0.001 M EDTA, pH 8.0) and washed for 2 h in 2 SSC at 25°C, followed
by 0.1 SSC at 60°C for 1 h, dehydrated in a series of ethanols, air dried,
and processed for emulsion autoradiography. Autoradiogramswere gen-
erated by apposing the labeled tissue to max Hyperfilm (Amersham
Biosciences) for 2 weeks.
In situ hybridization data analysis. For quantification of GAD and
NMDAR1A mRNA expression, films from dry-film autoradiography
were scanned at high resolution. For measurement of the areas lacking
GAD andNMDAR1AmRNA, we used an AnalySIS image software (Soft
Imaging System).
SDS-PAGE and Western blotting of mitogen-activated protein kinases.
PFC was lysed in the following (in mM): 15 Tris-HCl, pH 7.5, 150 NaCl,
1 EDTA, 1 EGTA, and 1 PMSF (all from Sigma). The homogenized was
centrifuged at 12,000  g for 20 min at 4°C. Protein content of the
samples was estimated by the method of microLowry using standard of
BSA (Fryer et al., 1986); 25–50 g of protein was loaded for each lane.
Protein samples were separated by SDS-PAGE (10%) and transferred to
a nitrocellulose membrane (Hybond-C extra; Amersham Biosciences).
Membranes were blocked with blocking buffer (5% milk in TBS: 20 mM
Tris-HCl, pH 7.5, 500 mM NaCl, and 0.05% Tween 20) for 1 h at room
temperature. Membranes were then incubated using the following anti-
bodies: anti-stress-activated protein kinase (SAPK)/c-Jun N-terminal
protein kinase (JNK), anti-p38, anti-extracellular signal-regulated kinase
1/2 (ERK1/2), anti-Akt1, and anti-cAMP response element-binding pro-
tein 1 (CREB-1) (1:1000) for 1 h at room temperature in blocking buffer
(5% milk in TBS); and anti-phosphorylated (P)-SAPK/JNK (Thr183/
Tyr185), anti-P-p38 (Tyr 182), anti-P-Akt (Thr 308), anti-P-CREB-1
(Ser 133), and anti-P-ERK1/2 (1:500) overnight at 5°C in blocking buffer
(5%milk in TBS). All antibodies used were from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA), and anti-SAPK/JNK and anti-P-SAPK/JNK were
fromCell Signaling Technology (Lake Placid, NY). After incubationwith
the primary antibodies, all membranes were
washed in TBST, incubated with peroxidase-
conjugated anti-Ig secondary antibodies (Da-
koCytomation, Produktionsvej, Denmark) at a
dilution of 1:3000 for 1 h at room temperature
in TBST. Proteins were visualized using West-
ern blotting chemiluminescence luminal re-
agent (Santa Cruz Biotechnology). Nonphos-
phorylated antibodies were used as loading
controls. All experiments were repeated in trip-
licate. The products were analyzed by densi-
tometry using the Quantity One 1-D Analysis
software (Bio-Rad, Hercules, CA).
Reverse transcriptase-PCR.The left PFCwas dissected from each rat 6 h
after treatment, snap frozen in liquid nitrogen, and stored at 80°C.
Tissue samples were homogenized in TRIzol reagent (Invitrogen, Carls-
bad, CA), using 1 ml of TRIzol per 50–100 mg of tissue. Total RNA was
extracted from the tissue according to the suggested protocol of theman-
ufacturer. The RNA was resuspended in PCR-grade water, and the con-
centration was calculated by A260 measurement. RNA quality was as-
sessed by electrophoresis on a 1% agarose gel.
First-strand cDNA was synthesized from 3 g of each RNA using 200
ng of random hexamer primers and 0.5 mM dNTPs. The samples were
incubated at 25°C for 10min and heated at 65°C for 5min. Afterward, 10
mM DTT, 100 U RNAseOUT Recombinant Ribonuclease Inhibitor (In-
vitrogen), and 1 first-strand buffer (in mM: 250 Tris-HCl, pH 8.3, 375
KCl, and 15 MgCl2) were added. Samples were heated at 42°C for 2 min
and then 200 U of Moloney murine leukemia virus reverse transcriptase
(RT) (SuperScript II; Invitrogen) were added to each tube. After incuba-
tion at 42°C for 50 min, the reaction was inactivated by heating at 70°C
for 15 min.
Triplicate reverse transcription reactions were performed along with
an additional reaction in which the reverse transcriptase enzyme was
omitted to allow for assessment of genomic DNA contamination in each
sample.
PCR was performed with 5 l of cDNA in 20 l of PCR reaction mix
containing 40 pmol of each primer (Table 2), 0.4 mM dNTPs, 2.5 U of
TaqDNA polymerase, 1.5 mMMgCl2, and 1 PCR buffer (200 mM Tris-
HCl, pH 8.4, and 500 mM KCl). To determine optimal experimental
conditions for relative quantification of transcripts, RT-PCRwas prelim-
inary tested at several cycle numbers (20–40 cycles) with variable cDNA
concentrations. Samples were placed in a PTC-100 PCR system (MJ
Research, Watertown, MA) at 94°C for 5 min, followed sequentially by a
cyclic phase of 26 cycles of denaturation at 94°C for 30 s, annealing at
55°C for 45 s, and extension at 72°C for 45 s, followed by a final elonga-
tion step at 72°C for 7 min. Concurrently, RT-PCR amplification of
-actin was performed as an internal control for variations in the effi-
ciencies of RNA isolation and RT.
Amplified products were separated by electrophoresis on a 1% agarose
gel, visualized over a UV transilluminator, and then photographed. The
products were analyzed by densitometry using AnalySIS software, and
quantities of each product were calculated relative to -actin.
Statistical analysis. Results are typically expressed as mean  SD.
Means were compared by one-way ANOVA. The least significance dif-
ference (LSD) test was used for post hocmultiple range comparisons.
Results
Changes in body and adrenal gland weights
Stress exerted a negative effect on the bodyweight gain after the
injection of LPS: whereas nonstressed animals maintained their
weight through the experiment, stressed rats lost 12.7% ( p 
0.01) (Fig. 1A). Conversely, stress caused an increase of 26.5% in
the adrenal gland weight ( p  0.05) (Fig. 1B) and 43.9% in the
adrenal gland weight/body weight ratio ( p  0.01) (Fig. 1B).
Bodyweight and adrenal weight alterations are typical effects of
stress; these results agree with those of Gamaro et al. (2003),
showing that the variate stress model applied to actually stressed
animals.
Figure 1. Effect of stress on the body and adrenal glandweights of LPS-injected animals. A,
Body weight at the beginning and the end of the treatment of nonstressed and stressed ani-
mals. Results are expressed in grams and are themean SD of five independent experiments.
Statistical significance (Student’s t test) compared with the nonstressed rats: *p 0.01. B,
Adrenal weight (in milligrams; bars) and adrenal weight/body weight ratio (in milligrams per
gram; circles) at the beginning and the end of the treatment of nonstressed and stressed ani-
mals. Results are mean SD of five independent experiments. Statistical significance (Stu-
dent’s t test) comparedwith the nonstressed rats: #p 0.05 for bodyweight; *p 0.01 for the
adrenal weight/body weight ratio.
Table 2. Primers for RT-PCR
Target mRNA Forward (F) and reverse (R) primers Expected product size (bp) Reference
IL-1 F, 5-CAGGATGAGGACATGAGCACC-3 447 Rostworowski et al., 1997
R, 5-CTCTGCAGACTCAAACTCCAC-3
TNF- F, 5-TACTGAACTTCGGGGTGATTGGTCC-3 297 Meltzer et al., 1998
R, 5-CAGCCTTGTCCCTTGAAGAGAACC-3
IL-6 F, 5-AAAATCTGCTCTGGTCTTCTGG-3 290 Lee et al., 2005
R, 5-GGTTTGCCGAGTAGACCTCA-3
-Actin F,5-TGTGATGGTGGGAATGGGTCAG-3 514 Rostworowski et al., 1997
R,5-TTTGATGTCACGCACGATTTCC-3
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Effect of stress on the cortical amounts
of DA and DOPAC
Variate stress increased amounts of DA in
the cortex, with peaks of nearly fourfold
and twofold over the control values at days
2 and 8, respectively, after the beginning of
the treatment (Table 3). The effect on
DOPAC was similar, with peaks of ap-
proximately twofold and threefold over
the control values at days 2 and 4, respec-
tively (Table 3). These results are in agree-
ment with others, showing alterations in
dopamine content after stress (Gamaro et
al., 2003) and a special sensitivity of PFC
dopaminergic neurons to different types
of stress (Feenstra et al., 1998; Abekawa et
al., 2000) compared with subcortical re-
gions (Matsumoto et al., 2005). The
changes observed in the parameters men-
tioned above may be considered an index
of the effectiveness of the chronic variate
stress model.
Effect of LPS and stress on microglia
Microglial cells become activated (change
of morphology from resting resident ram-
ified microglia with two or three fine pro-
cesses to round cells resembling tissue
macrophages) and proliferate when chal-
lenged. Injection of vehicle in nonstressed
animals (Fig. 2B,G) produced a slight mi-
croglial reaction, and it had a mild effect
on stressed animals (174.9% of control
values; p 0.01) (Fig. 2C,G), whereas LPS
injection induces a stronger activation
(259.0% compared with the vehicle-
injected animals; p  0.01) (Fig. 2D,G).
Combination of stress and LPS produced
an additive effect (415.9% compared with
the vehicle-injected animals; p  0.01)
(Fig. 2E,G) that was highly reduced for
RU486 (218.1% compared with the
vehicle-injected animals) (Fig. 2F,G).
Effect of LPS and stress on astroglia
We found a moderate astrogliosis around
the injection site of vehicle in nonstressed animals without loss of
GFAP immunostaining (Fig. 3B,G), although we observed dam-
age in stressed animals (0.15 mm2; p  0.01 compared with
control) (Fig. 3C,G). Astroglia disappeared around the injection
site of LPS, showing an area absent of GFAP-positive structures
but surrounded by hyper-reactive astrocytes (0.34mm2; p 0.01
compared with the vehicle-injected animals) (Fig. 3D,G). Stress
reinforces the effect of LPS in a synergistic manner, producing an
increase in the area lacking astrocytes (0.83 mm2; p 0.01 com-
pared with the vehicle-injected animals) (Fig. 3E,G). This effect
was reduced for RU486 (0.15 mm2) (Fig. 3F,G).
Effect of LPS and stress on neuronal populations
Additional NeuN immunostaining was performed to detect neu-
rons in general and in situ hybridization for GAD67 and
NMDAR1A mRNA expression, which coexpressed in PFC, for
detecting GABAergic neurons. Immunohistochemistry with
NeuN resulted in the staining of both nucleus and cytoplasm
(Fig. 4). This pattern was also seen in the PFC of vehicle-injected
rats (Fig. 4B,G) and in the contralateral (untouched) PFC after
LPS injection. Stress induces a loss of NeuN-positive neurons
around the injection site of vehicle (0.52 mm2, p  0.05 com-
pared with the loss produced for the injection of vehicle in con-
trol animals, 0.02mm2) (Fig. 4C,G) similar to that observed after
LPS-injection in nonstressed animals ( p  0.05 compared with
control) (Fig. 4D,G). When injected in stressed rats, an additive
effect was observed for LPS ( p  0.05 compared with control)
(Fig. 4E,G). This effect was reduced for RU486 (0.27 mm2) (Fig.
4F,G).
The GABAergic system in the PFC represents an abundant
neuronal population, therefore showing a high level of expres-
sion of GAD67 mRNA (Fig. 5). We evaluated the effect of stress
and LPS on the GABAergic population by injecting either vehicle
or LPS in nonstressed and stressed animals. The specificity of the
Table 3. Cortical amounts of DA and DOPAC in control and stressed rats
DA DOPAC
Time (d) Control Stressed Control Stressed
0 45.1 2.5 45.8 2.2 57.0 8.8 56.9 6.7
2 45.2 2.2 168.9 22.3** 56.2 7.9 122.8 22.0**
4 45.3 2.6 47.3 11.4 55.8 7.0 183.9 31.8**
8 45.5 3.2 85.8 15.2* 59.8 3.9 26.2 4.5**
10 45.7 1.7 55.4 14.4 54.8 5.3 62.6 12.8
At different timepoints after treatment (0, 2, 4, 8, and 10 d), animalswere killed, and the prefrontal cortexwas dissected out and processed for DA andDOPAC
quantification by HPLC, as described in Material and Methods. Numbers are expressed as nanograms per gram of wet tissue and are mean SD of five
independent experiments. *p 0.05, **p 0.01, statistical significance (Student’s t test) compared with control animals.
Figure 2. Effect of stress and LPS in microglia. A, Schematic representation of the injections site in the prefrontal cortex. B,
Coronal section showing a slight OX-6 immunoreactivity in a saline-injected nonstressed animal. C, OX-6 activation in a vehicle-
injected stressed animal. D, Immunoreactivity in an LPS-injected nonstressed animal. The arrow points to the site of injection of
2 g of LPS. Microglial reaction was mild. E, OX-6 immunoreactivity in an LPS-injected stressed animal. Microglial reaction is
stronger andmore widely distributed around the injection point (arrow). F, Treatment with RU486 reduces OX-6 activation in an
LPS-injected stressed animal. Scale bar, 250 m. G, Quantification of changes on the microglial population at the end of the
treatments. Results are mean SD of four independent experiments and are expressed as positive cells per square millimeter.
Statistical signification (one-way ANOVA, followed by the LSD post hoc test for multiple comparisons): a, compared with the
control, vehicle-injected nonstressed animals; b, compared with the vehicle-injected stressed animals; c, compared with the
LPS-injected nonstressed animals; d, compared with the LPS-injected stressed animals; p 0.01. C, Control, vehicle injected in
the PFC of nonstressed animals; S, vehicle injected in the PFC of stressed animals; L, LPS injected in the PFC of nonstressed animals;
SL, LPS injected in the PFC of stressed animals; SLRU, stressed animals intracortically injected with LPS and treated with RU486.
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signals generated by the antisense-strand RNA probe was also
confirmed using a sense probe (data not shown). Neuronal loss
was not significant after injection of vehicle in nonstressed rats
(Fig. 5B,G) and increased slightly in stressed animals (152.2% of
control values) (Fig. 5C,G) but was more evident after the injec-
tion of LPS in nonstressed animals (280.0% compared with the
vehicle-injected animals; p  0.01) (Fig. 5D,G). Stress and LPS
produced a synergistic effect (890.0% comparedwith the vehicle-
injected animals; p 0.01) (Fig. 5E,G). RU486 reduced the areas
losing expression of GAD67 mRNA to 200.0% (compared with
the vehicle-injected animals) (Fig. 5F,G).
NMDAR1A mRNA detected by in situ hybridization was
sparsely distributed throughout the PFC (Fig. 6). Sections hy-
bridized with the sense NMDAR1A probe were used as control
for nonspecific labeling (data not shown). The loss ofNMDAR1A
mRNA expression observed after vehicle injection in nonstressed
animals was reduced to the injection track (0.37 mm2) (Fig.
6B,G). Vehicle-injection in stressed animals (181.8% compared
with the vehicle-injected animals; p 0.01) (Fig. 6C,G) was sim-
ilar in LPS-injected animals (207.3% compared with the vehicle-
injected animals; p 0.01) (Fig. 6D,G). NMDAR1AmRNA loss
increased when LPS was injected into stressed rats (298.0% com-
pared with the vehicle-injected animals; p  0.01) (Fig. 6E,G).
Again, this effect was reduced for RU486 near to control values
(122.7% compared with the vehicle-injected animals) (Fig.
6F,G).
Effect of LPS and stress on the
expression of BDNF mRNA
Animals injected with vehicle displayed
few BDNF mRNA-expressing cells in this
structure. These cells were so scarce that
we could not find more than one or two
positive cells per section (Fig. 7A,F). Sim-
ilar results were found when vehicle was
injected into stressed animals (Fig. 7B,F).
LPS injections increased this number by a
factor of 12 ( p  0.01) (Fig. 7C,F),
whereas the addition of stress synergisti-
cally increased this factor to nearly 43 ( p
0.01) (Fig. 7D,F). This strong upregula-
tion of a subset of cortical neurons ex-
pressing BDNF mRNA was confined to
around the injection site. RU486 reduced
the number of BDNF mRNA-expressing
cells to ninefold of the control (Fig. 7E,F).
Effect of LPS and stress at the tumor
necrosis factor-, interleukin-1, and
interleukin-6 levels
Given that stress exacerbated the LPS ef-
fect, we next sought to determine whether
it was attributable to the increase of in-
flammatory mediators or to a direct effect
of stress on microglia activation. RT-PCR
analysis showed that the mRNAs for the
proinflammatory cytokines tumor necro-
sis factor- (TNF-), interleukin-1 (IL-
1), and Il-6 were induced 6 h after LPS
treatment. The expression levels of TNF-
mRNA in the PFC (Fig. 8A,B) were af-
fected by stress and LPS. So, stress in-
creased expression level to 128.6% of con-
trol values ( p 0.01). Similar results were
found after LPS injection in nonstressed animals (136.9% com-
pared with vehicle-injected animals; p  0.01). When LPS was
injected in stressed animals, expression levels of TNF- reached
153.6% of control vehicle-injected nonstressed animals ( p 
0.01). RU486 treatment reduced expression levels to 120.2% of
controls ( p 0.01).
The expression levels of IL-1 mRNA (Fig. 8A,C) did not
change in vehicle-injected stressed animals (100.9% compared
with control) but increased in LPS-injected nonstressed animals
(156.4% of vehicle-injected nonstressed animals; p 0.01). Sim-
ilar levels were found when LPS was injected in stressed animals
(153.8%; p  0.01). RU486 reduced IL-1 expression levels to
control values (108.6% of controls).
Similar to IL-1, the expression levels of IL-6 in PFC (Fig.
8A,D) did not change in vehicle-injected stressed animals
(113.5% compared with control) but increased in LPS-injected
nonstressed animals (158.7% of vehicle-injected nonstressed an-
imals; p  0.01). Expression levels in LPS-injected stressed ani-
mals reached 165.9% ( p  0.01) of controls. RU486 reduced
expression levels to 130.0% of controls ( p 0.01).
Effect of LPS and stress on the levels of total and
phosphorylated JNK, p38, ERK, Akt, and CREB
Activation of mitogen-activated protein kinases (MAPKs) was
determined by Western blot analysis using specific antibodies of
the phosphorylated and nonphosphorylated forms of JNK, p38,
Figure 3. Effect of stress and LPS in astroglia. A, Schematic representation of the injection sites in the prefrontal cortex. B,
Coronal section showing GFAP immunoreactivity in a saline-injected nonstressed animal. Loss of astrocytes is restricted to the
needle track. C, Loss of GFAP immunoreactivity in a vehicle-injected stressed animal. D, Coronal section showing GFAP immuno-
reactivity in anLPS-injectednonstressedanimal. Thearrowpoints to the site of injectionof 2gof LPS.GFAPexpressionwasmore
intense around the area lacking immunoreactivity. E, GFAP immunoreactivity in an LPS-injected stressed animal. The area lacking
immunostaining is clearly larger. F, RU486 prevented the loss of astrocytes in an LPS-injected stressed animal. Scale bar, 250m.
G, Quantification of the areas losing GFAP immunostaining. Results are mean SD of four independent experiments and are
expressed as squaremillimeters. Statistical significance (one-way ANOVA, followed by the LSD post hoc test for multiple compar-
isons): a, compared with the control, vehicle-injected nonstressed animals; b, compared with the vehicle-injected stressed ani-
mals; c, compared with the LPS-injected nonstressed animals; d, compared with the LPS-injected stressed animals; p 0.01. C,
Control, vehicle injected in the PFC of nonstressed animals; S, vehicle injected in the PFC of stressed animals; L, LPS injected in the
PFC of nonstressed animals; SL, LPS injected in thePFC of stressed animals; SLRU, stressed animals intracortically injectedwith LPS
and treated with RU486.
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ERK, Akt, and the transcription factor
CREB. Neither stress nor LPS produced
significant changes in the total amounts of
these proteins (Fig. 9). On the contrary,
phosphorylated levels were altered. LPS
induced an increase in P-JNK (from31.8%
in control animals to 40.6% in LPS-
injected animals; p 0.05; percentage val-
ues are relative to the total amount of the
studied protein in control animals). This
increase was reinforced for stress (49.9%;
p  0.05) but decreased to 23.9% of con-
trol animals after the treatment with
RU486. P-p38 MAPK levels were also al-
tered: LPS induced a strong increase (from
17.0% in control to 33.9% in LPS-injected
animals; p  0.01), whereas LPS injected
in stressed animals raised the levels to
43.8% of controls ( p  0.01). Again,
RU486 reduced the levels to 24.9% of con-
trols. P-ERK levels changed after the injec-
tion of vehicle in stressed animals, increas-
ing from 78.1% in control to 102.8% in
stressed animals ( p 0.01). The effect was
similar in nonstressed LPS-injected ani-
mals (105.6% of controls; p  0.01) and
reinforced when LPS was injected in
stressed animals (130.3% of controls; p
0.01). RU486 treatment prevents these
changes, keeping P-ERK levels close to
control values. The term Akt generally re-
fers to Akt1, one of the three knownmem-
bers of the Akt gene family (Brazil and
Hemmings, 2001). Although it is likely
that the three Akt proteins have at least
some nonoverlapping functions, they have yet to be fully under-
stood. We found that Akt phosphorylation levels were similar in
all treatments and not significantly different from controls. Phos-
phorylation of CREBwas also examined byWestern blot analysis
(Fig. 9). P-CREB was reduced after the injection of vehicle
(19.6% of controls; p  0.01) and LPS (22.2% of control; p 
0.01) in nonstressed animals and after the injection of LPS into
stressed animals (21.9%; p  0.01) compared with the control
values (66.8% of control). Again, RU486 prevented these
changes, keeping P-CREB levels close to control values (83.5% of
control).
Discussion
It has been shown previously that sensitivity of neurons to in-
flammation depends on both its duration and the region affected
(Willard et al., 1999; Herrera et al., 2000; Kim et al., 2000). For
instance, neurons from the dorsal raphe nuclei, hippocampus, or
cortex were relatively insensitive to a single LPS injection at doses
as high as 10g. Interestingly, our results show that the response
to LPS in PFC was significantly stronger in stressed than in non-
stressed animals: it was shown as a stronger OX-6 reaction, along
with the induction of the proinflammatory cytokines TNF- but
not IL-1 and Il-6. Proinflammatory cytokines are known to
increase in the inflammatory process induced by LPS. We also
found a greater loss of GFAP immunoreactivity in the stressed
animals. This pattern is maintained in the neuronal populations,
showing a greater loss of NeuN-positive neurons in the stressed
animals accompanied by the loss of cells expressing GAD67 and
NMDAR1AmRNAs, which coexpressed in PFCGABAergic neu-
rons. The effect of vehicle injection in stressed animals is gener-
ally lower than that found after the injection of LPS in non-
stressed animals. The effects produced by LPS alone can be
caused exclusively by the inflammatory response because it is not
believed to exert a major direct influence on the HPA axis (Seo
and Rivier, 2001). However, the increased neuronal damage pro-
duced by LPS in stressed animals could indicate a cooperative
effect of chronic stress and inflammation.
Stress is able to enhance neuronal damage in some conditions;
previous exposure to social stress increases infarction volume and
exacerbates cognitive deficits associated with transient cerebral
ischemia (Sugo et al., 2002). The mechanism underlying the ef-
fects of stress on stroke outcome likely involves corticosterone
acting through GR to increase subsequent ischemia-induced
neuronal death (Craft et al., 2005).
Deleterious consequences of prolonged exposure to an excess
of glucocorticoids have beenmainly described for the hippocam-
pus; atrophy of dendrites and neuronal loss has been reported
after corticosterone treatment (Sapolsky et al., 1985; Woolley et
al., 1990). In the presence of glucocorticoids, both in vitro and in
vivo, hippocampal neurons becomemore vulnerable to ischemia
(Sapolsky and Pulsinelli, 1985;Morse andDavis, 1990), hypogly-
cemia (Tombaugh and Sapolsky, 1992; Tombaugh et al., 1992),
and exposure to antimetabolites (Packan and Sapolsky, 1990;
McIntosh et al., 1998) and various neurotoxins (Hortnagl et al.,
1993).
Damages found in PFC could be caused by the increase of
Figure 4. Effect of stress and LPS on cortical neurons. A, Schematic representation of the injection site into the prefrontal
cortex. B, Coronal section showing NeuN immunoreactivity after the injection of vehicle in nonstressed animals. The loss was
restricted to the injection track. C, NeuN immunoreactivity after the injection of vehicle in stressed animals. Stress causes an
appreciable loss of cortical neurons.D, Coronal section showingNeuN immunoreactivity after the injection of 2g of LPS into the
prefrontal cortex of nonstressed rats. Evenly distributed staining is disrupted around the injection site (arrow). E, NeuN immuno-
reactivity after the injection of 2g of LPS into the prefrontal cortex of stressed rats. The area lacking staining is larger. F, The
treatmentwithRU486highly diminished the loss ofNeuN-positive neurons causedby the combined action of LPS and stress. Scale
bar, 250m. G, Quantification of the areas losing NeuN immunostaining. Results are mean SD of four independent experi-
ments and are expressed as square millimeters. Statistical significance (one-way ANOVA, followed by the LSD post hoc test for
multiple comparisons): a, compared with the control, vehicle-injected nonstressed animals; b, compared with the vehicle-
injected stressed animals; c, compared with the LPS-injected nonstressed animals; d, compared with the LPS-injected stressed
animals; p 0.01. C, Control, vehicle injected in the PFC of nonstressed animals; S, vehicle injected in the PFC of stressed animals;
L, LPS injected in the PFC of nonstressed animals; SL, LPS injected in the PFC of stressed animals; SLRU, stressed animals intracor-
tically injected with LPS and treated with RU486.
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radical oxygen species (ROS), extracellular glutamate levels, ex-
cessive Ca2 influx, and BDNF induced by LPS in stressed ani-
mals. Involvement of ROS in the degenerative effects induced by
LPS intranigral injection has been described previously (Toma´s-
Camardiel et al., 2004). Moreover, it is known that stress induces
the formation of ROS (McIntosh and Sapolsky, 1996) and leads
to oxidative injury in various tissues, including blood (Oishi et
al., 1999) and brain (Liu et al., 1996). Overexcitation of glutamate
receptors seems to contribute to neurode-
generation at early stages of LPS infusion
(Glezer et al., 2003). Stress activates the
glutamatergic system in the PFC more in-
tensely than in other regions (Gilad et al.,
1990; Moghaddam, 1993; Karreman and
Moghaddam, 1996). The stress-induced
increase in dopamine release found by us
in the PFC at the beginning of the stressing
treatment could be a consequence of an
increased glutamatergic neurotransmis-
sion in this region (Jedema and
Moghaddam, 1996); this glutamate may
excite GABA neurons and induce their
death (Li et al., 2002), presumably with the
increase of intracellular Ca2 levels (El-
liott and Sapolsky, 1993). At the same
time, Harvey et al. (2004) reported that
stress–restress-mediated glucocorticoids
release produced a downregulation of hip-
pocampalNMDAreceptors and a decrease
in GABA. Li et al. (2002) demonstrated in
acute slices of rat limbic cortex that
NMDA receptors on the GABAergic neu-
rons were disproportionately more sensi-
tive to the antagonistic effects of MK-801
[()-5-methyl-10,11-dihydro-5H-dibenzo
[a,d] cyclohepten-5,10-imine maleate]
than to those on pyramidal neurons. Thus,
downregulation of presynaptic markers
for GABAergic interneurons may reflect a
chronic loss of the trophic influences of
NMDA receptor activation (Paulson et al.,
2003).
Another interesting result is the in-
crease in BDNF mRNA expression in PFC
during the injection of LPS in stressed rats.
Expression of BDNF changes in response to different stressors
and depends on the brain structure studied (Pizarro et al., 2004;
Xu et al., 2004; Rosenbrock et al., 2005). The increase in BDNF
expression found in our experiment could be a synergistic effect
produced by LPS toxicity and stress through the loss of GABAer-
gic neurons rather than being produced by stress directly. GABA
represses BDNF expression (Zafra et al., 1991; Heese et al., 2000;
Figure5. Effect of stress andLPSoncortical neuronsexpressingGAD67mRNA.A, Schematic representationof the injection site into theprefrontal cortex.B, Coronal section showingGAD67mRNA
expression after the injection of vehicle in nonstressed animals. The loss can be seen closely around the injection track (dashed-lined area). C, GAD67mRNA expression after the injection of vehicle
in stressed animals. Stress causes a slight loss of cortical neurons (dashed-lined area). D, Coronal section showing GAD67 mRNA in situ hybridization after the injection of 2g of LPS into the
prefrontal cortex of nonstressed rats. Normal expression is disrupted (dashed-lined area) around the injection site. Arrow shows the inert tracer. E, GAD67mRNA expression after the injection of 2
g of LPS into the prefrontal cortex of stressed rats. The area lacking staining (dashed-lined area) is larger. F, RU486 exerted a protective effect on the expression of GAD67 mRNA in stressed rats
injectedwith LPS. Scale bar, 1mm.G, Quantification of the areas losing GAD67mRNA expression. Results aremean SD of five independent experiments and are expressed as squaremillimeters.
Statistical significance (ANOVA, followed by the LSD post hoc test for multiple comparisons): a, compared with the control, vehicle-injected nonstressed animals; b, compared with the vehicle-
injected stressedanimals; c, comparedwith theLPS-injectednonstressedanimals; d, comparedwith theLPS-injected stressedanimals;p0.01. C, Control, vehicle injected in thePFCofnonstressed
animals; S, vehicle injected in the PFC of stressed animals; L, LPS injected in the PFC of nonstressed animals; SL, LPS injected in the PFC of stressed animals; SLRU, stressed animals intracortically
injected with LPS and treated with RU486.
Figure6. Effect of stress and LPS on cortical neurons expressingNMDAR1AmRNA.A, Schematic representation of the injection
site in the prefrontal cortex. B, Coronal section showing NMDAR1AmRNA expression after the injection of vehicle in nonstressed
animals. The loss can be seen closely around the injection track (dashed-lined area). C, NMDAR1A mRNA expression after the
injection of vehicle in stressed animals. Stress causes an appreciable loss of cortical neurons (dashed-lined area). D, NMDAR1A
mRNA in situ hybridization after the injection of 2 g of LPS into the prefrontal cortex of nonstressed rats. Evenly distributed
expression is disrupted (dashed-lined area) around the injection site. Arrow shows the inert tracer.E, NMDAR1AmRNAexpression
after the injection of 2g of LPS into the prefrontal cortex of stressed rats. The area lacking expression (dashed-lined area) is
larger. F, Loss of NMDAR1AmRNA expression induced by LPS and stress is reduced by the treatmentwith RU486. Scale bar, 1mm.
G, Quantification of the areas losing NMDAR1A mRNA expression. Results are mean SD of four independent experiments and
are expressed as square millimeters. Statistical significance (one-way ANOVA, followed by the LSD post hoc test for multiple
comparisons): a, comparedwith the control, vehicle-injectednonstressedanimals; b, comparedwith the vehicle-injected stressed
animals; c, comparedwith the LPS-injected nonstressed animals; d, comparedwith the LPS-injected stressed animals; p 0.01.
C, Control, vehicle injected in the PFC of nonstressed animals; S, vehicle injected in the PFC of stressed animals; L, LPS injected in
the PFC of nonstressed animals; SL, LPS injected in the PFC of stressed animals; SLRU, stressed animals intracortically injectedwith
LPS and treated with RU486.
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Marmigere et al., 2003), whereas LPS and stress activate glutama-
tergic (Karreman andMoghaddam, 1996; Glezer et al., 2003) and
dopaminergic (Abekawa et al., 2000; Gamaro et al., 2003; Matsu-
moto et al., 2005) systems, which induces BDNF expression
(Zafra et al., 1990, 1991; Kuppers and Beyer, 2001). Although
BDNF increases in pathological situations (Felderhoff-Mueser et
al., 2002) and seems to exert a protective activity (Tapia-
Arancibia et al., 2004), some evidence suggests that neurotro-
phins strengthen or may even cause neuronal damage under
certain pathological conditions through the induction of
NADPH-oxidase (Koh et al., 1995; Samdani et al., 1997; Kim et
al., 2002). Thus, BDNF could be involved in the increase of the
damage induced by inflammation in stressed animals.
All of these data allow us to suggest that inflammation along
with chronic stress induces a special situation that leads to in-
creased damage and loss of neurons. However, damage produced
by stress can be prevented. Inhibition of the rise of corticosteroids
levels during ischemia preserves cell survival after ischemia and
prevents seizures (Krugers et al., 1995, 1998, 1999; Smith-
Swintoski et al., 1996); also, GR blockade with RU486 (a potent
inhibitor of GR activation) prevents CA1 neuron loss 24 h after
constriction nerve injury (McCullers et al., 2002). It is also known
that RU486 reverses glucocorticoid-mediated vulnerability to
glutamate in a culturedmurine hippocampal cell line (Behl et al.,
1997a). We found that treatment with RU486 produced a signif-
icant protection, reducing OX-6 reaction and loss of GFAP im-
munoreactivity. RU486 also prevented the increase of the three
cytokines studied.
Figure 7. Effect of stress and LPS on BDNF mRNA expression in the prefrontal cortex. Dark-
field photographs were taken from emulsion-dipped slide sections. A, BDNF mRNA expression
after the injection of 2l of vehicle in the prefrontal cortex of nonstressed rats. Virtually no cells
are detectable around the injection site (arrow).B, BDNFmRNAexpression after the injection of
2l of vehicle into the prefrontal cortex of stressed rats. Cells are absent around the injection
track. C, BDNF mRNA expression after the injection of 2g of LPS into the prefrontal cortex of
nonstressed rats. A few cells can be seen around the injection site (arrow). D, BDNF mRNA
expression after the injection of 2 g of LPS into the prefrontal cortex of stressed rats. The
number of cells around the injection site (arrow) has increased. E, The increase in BDNF mRNA
expression inducedbyLPSand stress is diminishedby the treatmentwithRU486. Scalebars, 250
m. F, Quantification of the BDNF mRNA expression. Results are mean SD of four indepen-
dent experiments and are expressed as cells per section. Statistical significance (one-way
ANOVA, followed by the LSD post hoc test for multiple comparisons): a, compared with the
control, vehicle-injected nonstressed animals; b, compared with the vehicle-injected stressed
animals; c, compared with the LPS-injected nonstressed animals; d, compared with the LPS-
injected stressed animals; p  0.01. C, Control, vehicle injected in the PFC of nonstressed
animals; S, vehicle injected in the PFC of stressed animals; L, LPS injected in the PFC of non-
stressed animals; SL, LPS injected in the PFC of stressed animals; SLRU, stressed animals intra-
cortically injected with LPS and treated with RU486.
Figure 8. Effect of stress and LPS on the expression levels of TNF-, IL-1, and IL-6mRNAs.
Expression of TNF-, IL-1, and IL-6mRNAsweremeasured by RT-PCR in the prefrontal cortex
of rats from the different treatments assayed: C, control, vehicle injected in the PFC of non-
stressed animals; S, vehicle injected in the PFC of stressed animals; L, LPS injected in the PFC of
nonstressed animals; SL, LPS injected in the PFC of stressed animals; SLRU, stressed animals
intracortically injected with LPS and treated with RU486. A, Photographs from agarose gels
showing expression of mRNAs 6 h after injection of either vehicle or LPS into the left PFC.
-Actin mRNA expression served as control. B, Quantification of TNF- mRNA expression.
Stress and LPS increased expression levels in a similar way. TNF-mRNA induction was higher
when LPS and stress were combined. RU486 diminished expression levels. C, Quantification of
IL-1mRNA expression. Stress had no effect, whereas induction of IL-1 levels attributable to
LPS injection was similar in nonstressed and stressed animals. RU486 reduced IL-1 levels to
control values.D, Quantification of IL-6mRNA expression. Similar to IL-1, stress had no effect
on IL-6mRNAexpression levels, and the increase inducedby LPSwas reducedbyRU486. Results
are mean SD of four independent experiments and are expressed as percentage of-actin
mRNAexpression. Statistical significance (one-wayANOVA, followedby theLSDpost hoc test for
multiple comparisons): a, compared with the control, vehicle-injected nonstressed animals; b,
compared with the vehicle-injected stressed animals; c, compared with the LPS-injected non-
stressed animals; d, compared with the LPS-injected stressed animals; p 0.01.
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This pattern ismaintained in the neuronal populations, show-
ing a significant reduction of the loss of NeuN-positive neurons
and cells expressing GAD67 andNMDAR1AmRNAs.Moreover,
RU486 treatment also inhibits the increase in BDNF mRNA ex-
pression in PFC during the injection of LPS in stressed rats. The
protective effect of RU486 could be caused by its antiglucocorti-
coid effects combined with its antioxidant properties (Behl et al.,
1997b). The antiglucocorticoid effects could prevent excessive
intracellular Ca2 accumulation in neurons (Elliott and Sapol-
sky, 1993;McCullers et al., 2002). RU486 antioxidant effects may
mediate neuroprotection in CA1 pyramidal cells. It also prevents
oxidation of the low-density lipoprotein (Parthasarathy et al.,
1994) and the oxidative modification of proteins (Carpenter et
al., 1996).
This is also in agreement with the results found for MAPK
cascades, responsible for the transduction of neurotrophic sig-
nals.We found that stress, LPS (through cytokines such as TNF-
and IL-1), and the combination of both produced an increase in
the phosphorylation levels of JNK, p38, and ERK; this was pre-
vented by RU486 treatment. Activation of JNK/SAPK and p38 is
associated with promotion of apoptosis and plays an important
role in the pathogenesis of inflammatory responses (Walton et
al., 1998). Our results also show a marked reduction of CREB
phosphorylation that is prevented by RU486 treatment. This is in
agreement with previous work reporting that chronic stress in-
creased P-ERK but significantly reduced P-CREB expression in
PFC (Kuipers et al., 2003).We found that TNF- release induced
by LPS is reinforced by stress and is prevented by RU486.
All of these results suggest a relationship between the in-
flammatory process and the increased basal activity of the
HPA axis that have been repeatedly demonstrated in AD, in-
cluding increase in basal concentration of cortisol in plasma
(Belanoff et al., 2001) along with a higher incidence of chronic
stress adaptation failure in patients with AD (Pascualy et al.,
2000). It is well known that amyloid deposits are not exclusive
of AD patients but appear in most nondemented people after
the age of 65 years (Sparks et al., 1993). PFC and probably
other CNS structures could be less sensitive to inflammation
than to stress; a cooperative effect between the two processes
could explain the suggested relationship between stress and
AD, because a high susceptibility to distress leads to a double
risk of developing this disease (Wilson et al., 2003). This is also
in agreement with the first evidence of a genetic association
between the glucocorticoid system and AD reported by de
Quervain et al. (2004). Set-association analysis revealed a rare
haplotype in the 5 regulatory region of the gene encoding
11-hydroxysteroid dehydrogenase type 1 (HSD11B1) associ-
ated with a sixfold increased risk for sporadic AD. HSD11B1
controls tissue levels of biologically active glucocorticoids and
thereby influences neuronal vulnerability. These results also
point to the possibility of using RU486 in AD, because differ-
ent assays show that RU486 slows the progression of cognitive
decline in this disease (Belanoff et al., 2002; DeBattista and
Belanoff, 2005).
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